Benicia, CA (Vocus) October 15, 2008-- AcroMetrix, a leading provider of quality control products and services for nucleic acid testing in blood screening, announced today the launch of the West Nile Virus (WNV) Training Panel. The six-member panel is intended for use in evaluating operator qualification as well as assisting in verification activities for WNV assays.
Laboratories bringing on new WNV assays can use the WNV Training Panel to verify that their test results are consistent across different laboratories, platforms, operators and assay formats. The panel members cover a broad range of positive and negative values, demonstrating performance ranges similar to those established by the assay manufacturer, and helping to provide a complete assessment of operator qualification.
"We believe it is important to provide the highest quality training and verification materials that can assist the laboratory in bringing assays online smoothly and painlessly," said Michael Eck, President and CEO. "The WNV Training Panel is designed specifically for use with commercial WNV assays to help the lab achieve their quality control objectives."
The WNV Training Panel is developed using whole virus in a normal human plasma matrix, creating a quality control material very similar to a naturally occurring patient sample that allows monitoring of the entire NAT process from extraction to amplification and detection. Use of the WNV Training Panel, along with VeriSure Pro external run controls, helps to strengthen a laboratory's complete quality control program. This product is for Research Use Only. Not for Use in Diagnostic Procedures.
About AcroMetrix
AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. All AcroMetrix procedures are developed and manufactured under QSR, cGMP, according to applicable FDA and ISO/EC standards. For more information on AcroMetrix please visit the company web site at www.acrometrix.com.
CONTACT: Alexis Stimpfle, (phone) +1-707-746-8888 ext. 144, or ams@acrometrix.com
Web site: http://www.acrometrix.com//
###
|
